- Home
- BCRX vs IHS Comparison
BCRX vs IHS Comparison
Compare BCRX & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | IHS |
|---|---|---|
| Founded | 1986 | 2001 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.8B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BCRX | IHS |
|---|---|---|
| Price | $8.37 | $8.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $20.82 | $8.29 |
| AVG Volume (30 Days) | ★ 4.4M | 1.1M |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | $17.26 |
| Revenue Next Year | $12.55 | $7.87 |
| P/E Ratio | ★ N/A | $5.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $5.50 |
| 52 Week High | $11.22 | $8.95 |
Technical Indicators
Market Signals| Indicator | BCRX | IHS |
|---|---|---|
| Relative Strength Index (RSI) | 42.68 | 53.91 |
| Support Level | $8.13 | $8.14 |
| Resistance Level | $8.68 | $8.34 |
| Average True Range (ATR) | 0.33 | 0.05 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 25.21 | 45.95 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria and Sub-Saharan Africa. The majority of its revenue is derived from Nigeria.